PL1684851T3 - Sposoby przygotowywania buforów polimerowych do elektrotransportu - Google Patents

Sposoby przygotowywania buforów polimerowych do elektrotransportu

Info

Publication number
PL1684851T3
PL1684851T3 PL04811757T PL04811757T PL1684851T3 PL 1684851 T3 PL1684851 T3 PL 1684851T3 PL 04811757 T PL04811757 T PL 04811757T PL 04811757 T PL04811757 T PL 04811757T PL 1684851 T3 PL1684851 T3 PL 1684851T3
Authority
PL
Poland
Prior art keywords
methods
drug solution
preparing polymeric
buffer formulations
polymeric buffer
Prior art date
Application number
PL04811757T
Other languages
English (en)
Inventor
David Rauser
Rama Padmanabhan
Joseph B Phipps
Janardhanan Subramony
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of PL1684851T3 publication Critical patent/PL1684851T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0412—Specially adapted for transcutaneous electroporation, e.g. including drug reservoirs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyethers (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Graft Or Block Polymers (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
PL04811757T 2003-11-19 2004-11-19 Sposoby przygotowywania buforów polimerowych do elektrotransportu PL1684851T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52347003P 2003-11-19 2003-11-19
PCT/US2004/039096 WO2005051484A1 (en) 2003-11-19 2004-11-19 Methods for preparing polymeric buffer formulations for electrotransport applications
EP04811757A EP1684851B1 (en) 2003-11-19 2004-11-19 Methods for preparing polymeric buffer formulations for electrotransport applications

Publications (1)

Publication Number Publication Date
PL1684851T3 true PL1684851T3 (pl) 2007-12-31

Family

ID=34632786

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04811757T PL1684851T3 (pl) 2003-11-19 2004-11-19 Sposoby przygotowywania buforów polimerowych do elektrotransportu

Country Status (12)

Country Link
US (2) US20050142531A1 (pl)
EP (2) EP1689489B1 (pl)
JP (2) JP2007516962A (pl)
KR (2) KR20060130042A (pl)
AT (2) ATE387240T1 (pl)
CA (2) CA2546405A1 (pl)
DE (2) DE602004012143T2 (pl)
DK (1) DK1684851T3 (pl)
ES (1) ES2291975T3 (pl)
PL (1) PL1684851T3 (pl)
PT (1) PT1684851E (pl)
WO (2) WO2005051484A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY28935A1 (es) 2004-06-03 2005-07-29 Alza Corp Sistema y metodo para la administracion transdermica de un anticoagulante
CA2645641A1 (en) * 2006-03-21 2007-09-27 Alza Corporation Hydratable polymeric ester matrix for drug electrotransport
EP2101864A2 (en) * 2006-12-20 2009-09-23 ALZA Corporation Anode for electrotransport of cationic drug
US20090105632A1 (en) * 2007-10-18 2009-04-23 Padmanabhan Rama V Electrotransport Of Lisuride

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5853383A (en) * 1995-05-03 1998-12-29 Alza Corporation Preparation for formulations for electrotransport drug delivery
WO1997012644A1 (en) * 1995-09-29 1997-04-10 Becton Dickinson And Company Improved iontophoretic reservoir apparatus
ES2230727T3 (es) * 1997-11-12 2005-05-01 Alza Corporation Procedimiento de administracion dermal de polipeptidos.
US6039977A (en) * 1997-12-09 2000-03-21 Alza Corporation Pharmaceutical hydrogel formulations, and associated drug delivery devices and methods
WO2002089803A1 (en) * 2001-05-07 2002-11-14 Sankyo Company, Limited Composition for iontophoresis

Also Published As

Publication number Publication date
WO2005051484A1 (en) 2005-06-09
CA2546405A1 (en) 2005-06-09
PT1684851E (pt) 2007-12-03
ES2291975T3 (es) 2008-03-01
JP2007511617A (ja) 2007-05-10
DE602004012143T2 (de) 2008-06-19
KR20070001877A (ko) 2007-01-04
CA2546399A1 (en) 2005-06-09
EP1684851B1 (en) 2007-08-22
EP1684851A1 (en) 2006-08-02
EP1689489A1 (en) 2006-08-16
JP2007516962A (ja) 2007-06-28
EP1689489B1 (en) 2008-02-27
DE602004012143D1 (de) 2008-04-10
US20050142531A1 (en) 2005-06-30
DE602004008502T2 (de) 2008-01-03
ATE370766T1 (de) 2007-09-15
US20050129655A1 (en) 2005-06-16
WO2005051485A1 (en) 2005-06-09
KR20060130042A (ko) 2006-12-18
ATE387240T1 (de) 2008-03-15
DK1684851T3 (da) 2008-01-07
DE602004008502D1 (de) 2007-10-04

Similar Documents

Publication Publication Date Title
MXPA06001821A (es) Una composicion probiotica, liquida, estable, preparacion y aplicaciones de la misma.
AU2002350216A1 (en) Low equivalent weight ionomer
PT1412384E (pt) Formulação estável de glp-1 modificado
SG147435A1 (en) Derivatives of n-heterocyclylmethylbenzamides, preparation method thereof and application of same in therapeutics
WO1997044065A3 (en) Device and method for encapsulated gene therapy
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
IL171875A0 (en) Pioglitazone salts,such as pioglitazone sulfate, and pharmaceutical compositions and processes using the same
WO2002053181A8 (en) Enterohemorragic escherichia coli vaccine
WO2021158854A3 (en) Large gene vectors and delivery and uses thereof
WO2001010901A3 (en) Antimicrobial histone h1 compositions, kits, and methods of use thereof
PL1684851T3 (pl) Sposoby przygotowywania buforów polimerowych do elektrotransportu
WO2005012491A3 (en) Surface expression of biologically active proteins in bacteria
EP1590144A4 (en) PROCESS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE FORMULATIONS
MXPA05009527A (es) Implante labial y metodo para la insercion.
WO2003060066A3 (en) Nucleic acid delivery and expression
SG185137A1 (en) Biologically active peptides
BR9916726A (pt) HormÈnio do crescimento humano para estimular a mobilização de células tronco hematopoiéticas pluripotentes
AU6318301A (en) Cng3b: a novel cyclic nucleotide-gated cation channel
AU2001240540A1 (en) Method for the manufacture of recombinant trypsin
AU8488401A (en) Cng2b: a novel human cyclic nucleotide-gated ion channel
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
WO2004069196A3 (en) Novel compounds
AU2002241270A1 (en) Compositions for delivering biologically active drug and method of using the same
WO2004069199A3 (en) Marketing system for improving patient compliance and methods and devices relating to same
WO2003048206A3 (fr) Peptides agonistes de l'hormone de croissance et leurs applications